检索结果-内蒙古大学图书馆

Corrigendum to "The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection" [Antivir. Res. vol 192 (2021) 1-13/105121]

引用

Antiviral research 2022年 199卷 105245页

作者： Sandra Kendra Raini Yuki Takamatsu Shyam Prakash Dumre Shuzo Urata Shusaku Mizukami Meng Ling Moi Daisuke Hayasaka Shingo Inoue Kouichi Morita Mya Myat Ngwe Tun Department of Virology Institute of Tropical Medicine and Leading Program Graduate School of Biomedical Sciences Nagasaki University 1-12-4 Sakamoto Nagasaki 852-8523 Japan. Department of Virology 1 National Institute of Infectious Diseases 4-7-1 Gakuen Musashimurayama City Tokyo 208-0011 Japan. Central Department of Microbiology Tribhuvan University Kirtipur Kathmandu Bagmati 44601 Nepal. National Research Center for the Control and Prevention of Infectious Diseases (CCPID) Nagasaki University 1-12-4 Sakamoto Nagasaki 852-8523 Japan. Department of Immune Regulation Shionogi Global Infectious Diseases Division Institute of Tropical Medicine Nagasaki University 1-12-4 Sakamoto Nagasaki 852-8523 Japan. Laboratory of Veterinary Microbiology Joint Faculty of Veterinary Medicine Yamaguchi University Yamaguchi 753-8515 Japan. Department of Virology Institute of Tropical Medicine and Leading Program Graduate School of Biomedical Sciences Nagasaki University 1-12-4 Sakamoto Nagasaki 852-8523 Japan. Electronic address: moritak@nagasaki-u.ac.jp. Department of Virology Institute of Tropical Medicine and Leading Program Graduate School of Biomedical Sciences Nagasaki University 1-12-4 Sakamoto Nagasaki 852-8523 Japan. Electronic address: myamyat@tm.nagasaki-u.ac.jp.

来源：评论

Correction to: Healthy lifestyle index and risk of pancreatic cancer in the Women's Health Initiative

引用

Cancer causes & control : CCC 2023年第12期34卷 1157页

作者： Rita Peila Mace Coday Tracy E Crane Nazmus Saquib Aladdin H Shadyab Fred K Tabung Xiaochen Zhang Jean Wactawski-Wende Thomas E Rohan Department of Epidemiology and Population Health Albert Einstein College of Medicine 1300 Morris Park Avenue Bronx NY 10461 USA. rita.peila@***. Department of Preventive Medicine College of Medicine University of Tennessee Health Science Center Memphis TN USA. Behavioral Measurement and Interventions Cancer Prevention and Control Program University of Arizona Tucson AZ USA. College of Medicine at Sulaiman Al Rajhi University Al Bukayriyah Saudi Arabia. Herbert Wertheim School of Public Health and Human Longevity Science University of California San Diego La Jolla CA USA. Internal Medicine Division of Medical Oncology The Ohio State University College of Medicine and Comprehensive Cancer Center Columbus OH USA. Division of Epidemiology College of Public Health Comprehensive Cancer Center Ohio State University Columbus OH USA. Department of Epidemiology and Environmental Health School of Public Health University of Buffalo Buffalo NY USA. Department of Epidemiology and Population Health Albert Einstein College of Medicine 1300 Morris Park Avenue Bronx NY 10461 USA. thomas.rohan@***.

来源：评论

Improving Outcomes in Plasmablastic Lymphoma: A Multicenter Experience from an American Cohort

引用

Blood 2024年 144卷 573-573页

作者： Matthew Hamby Brian Egleston Zachary AK Frosch Raphael E. Steiner Ariela Noy Veronica Carvajal Seda S. Tolu Gaston Jean-Louis Jennifer E. Amengual Romil Patel Sairah Ahmed Timothy Voorhees Robert Baiocchi Andres Ramirez-Gamero Jorge J. Castillo Emily Hamburger Christopher Dittus Imran A. Nizamuddin Neha Mehta-Shah Nyein Nyein Thaw Dar Stefan K. Barta University of Pennsylvania Lancaster PA Fox Chase Cancer Center Philadelphia PA Department of Hematology/Oncology； Cancer Prevention and Control Research Program Fox Chase Cancer Center Philadelphia PA Lymphoma Service Department of Medicine Memorial Sloan Kettering Cancer Center New York NY Lymphoma Program Abramson Cancer Center University of Pennsylvania Philadelphia Division of Hematology & Oncology Columbia University Irving Medical Center New York City NY Columbia University New York NY Division of Hematology & Oncology Columbia University Irving Medical Center New York Department of Lymphoma and Myeloma The University of Texas MD Anderson Cancer Center Houston TX Department of Lymphoma/Myeloma and Stem Cell Transplantation The University of Texas MD Anderson Cancer Center Houston TX MD Anderson Cancer Center Houston TX Division of Hematology The Ohio State University Columbus OH James Comprehensive Cancer Center The Ohio State University Columbus OH Dana-Farber Cancer Institute Bing Center for Waldenström Macroglobulinemia Boston MA Dana-Farber Cancer Institute Harvard Medical School Boston MA Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill NC Division of Oncology Washington University School of Medicine St. Louis MO Siteman Cancer Center Washington University in St. Louis St Louis MO Siteman Cancer Center Washington University School of Medicine St. Louis Moffitt Cancer Center at Memorial Healthcare System Pembroke Pines FL Division of Hematology-Oncology Perelman Center for Advanced Medicine University of Pennsylvania Philadelphia PA Abramson Cancer Center University of Pennsylvania Philadelphia PA

Introduction: Plasmablastic lymphoma (PBL) is a rare subtype of large B-cell lymphoma first described in 1997 in a small cohort of persons living with HIV (HIV-PBL). Since then, it has been observed post-transplant (P...

Introduction: Plasmablastic lymphoma (PBL) is a rare subtype of large B-cell lymphoma first described in 1997 in a small cohort of persons living with HIV (HIV-PBL). Since then, it has been observed post-transplant (PTLD-PBL) and even in otherwise immunocompetent patients (IC-PBL). With no current well-defined standard of care, prognosis of PBL has historically been poor (median overall survival (OS) 7-15 months), although recent studies suggest modest improvements in survival. We aimed to better characterize disease characteristics, treatment patterns, and factors associated with outcomes in a large contemporary US cohort. Methods: Patients (pts) ≥ 18 years old with PBL diagnosed between 1/2005 and 12/2022 from 20 academic centers in the United States were identified. Data on pt and disease characteristics and treatment were collected from medical records. OS, progression-free survival (PFS), lymphoma-specific survival (LSS), treatment-related mortality (TRM), and non-relapse mortality (NRM) were calculated using the Kaplan-Meier method. Cox regression and Fine-Gray competing risk regression were used to assess the association between clinical factors and survival outcomes. Results: 331 pts with PBL were identified. The median age at diagnosis was 53 years (range 20-91y). 78% were male (n = 257). 46% had HIV-PBL (n = 151), 35% had IC-PBL (n = 117), 6% had PTLD-PBL (n = 20), and 13% had PBL with other immunosuppressed states (n = 43). 66% of pts were White (n = 219), 18% were Black/African American (n = 58), and 31% were Hispanic (n = 104). 74% of Black/African American and 52% of Hispanic pts were diagnosed with HIV-PBL, compared with only 37% of White pts. The median age at diagnosis was greater in the IC-PBL group (68y) than in the HIV-PBL and PTLD-PBL groups (46y and 55y, respectively; p < 0.001). Most pts presented with Stage IV disease (61%, n = 220). Bone marrow (BM) involvement was present in 22% (n = 73). 92% of pts had extranodal sites involved at presenta

来源：评论

Response to Editorial

引用

Helicobacter 2019年第2期24卷 e12558页

作者： Michael G Bruce Karen Miernyk Frank Sacco Timothy Thomas Brian McMahon Tom Hennessy Arctic Investigations Program Division of Preparedness and Emerging Infections National Center for Emerging Zoonotic and Infectious Diseases Centers for Disease Control and Prevention (CDC) Anchorage Alaska. Alaska Native Tribal Health Consortium Anchorage Alaska.

来源：评论

Reply to Mercuro et al

引用

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018年第8期67卷 1307-1308页

作者： Sarah Kabbani Adam L Hersh Daniel J Shapiro Katherine E Fleming-Dutra Andrew T Pavia Lauri A Hicks Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Atlanta Georgia. Division of Pediatric Infectious Diseases Department of Pediatrics University of Utah School of Medicine Salt Lake City. Boston Combined Residency Program in Pediatrics Boston Medical Center and Boston Children's Hospital Massachusetts.

来源：评论

1714. Testing a Novel Clinical Surveillance Case Definition for Invasive Mold Infections

引用

Open Forum Infectious Diseases 2019年第SUPPLEMENT_2期6卷 S628–S629页

作者： Beer, Karlyn Kelly, Hilary Blakney, Rebekah Chambers, Taylor Perry, Lewis Singleton, Sabrina Matkovic, Eduard Hale, Gillian Thomas, Stepy Oliver, Nora Dretler, Alexandra Tsay, Sharon Farley, Monica M Jackson, Brendan R CDC Atlanta Georgia Centers for Disease Control and Prevention Atlanta Georgia Georgia Emerging Infections Program Atlanta Georgia VA Health System/Georgia Emerging Infections Program Atlanta Georgia Georgia Emerging Infections Program/Georgia VA Health System Atlanta Georgia Emory University Georgia Emerging Infections Program Atlanta Georgia Emory University Atlanta Georgia Emory University Georgia Emerging Infectious Program Atlanta Georgia

BackgroundInvasive mold infections (IMI) such as aspergillosis and mucormycosis are often fatal among immunosuppressed patients and have caused high-profile outbreaks. Surveillance for IMI is challenging because disti...

Background Invasive mold infections (IMI) such as aspergillosis and mucormycosis are often fatal among immunosuppressed patients and have caused high-profile outbreaks. Surveillance for IMI is challenging because distinguishing a case from colonization or contamination is complex. The established case definition, Mycoses Study Group (MSG) criteria, lacks sensitivity. Because the need for surveillance remains, we designed a pilot IMI surveillance system within the Georgia Emerging Infections program. Here, we describe cases identified through this system, using both the MSG criteria and a novel, more sensitive clinical case definition. Methods To identify potential IMI cases, we captured fungal cultures positive for mold, histopathology specimens with evidence of fungal tissue invasion, and positive galactomannan results within a 60-day window at three large hospitals in Atlanta during March 2017–2018. We excluded dimorphic fungi and hair and nail specimens. Of 194 potential cases, we selected 24 for complete medical chart review. Two physicians classified cases as proven, probable, or non-case according to MSG criteria. Cases that partially met MSG probable criteria and included antifungal treatment were classified as clinical cases; definitions were mutually exclusive (Figure 1). Results Of 24 potential IMI cases, 16 (66%) met an IMI case definition, including 5 proven, 2 probable and 9 clinical cases. Inter-rater agreement was 92%., Most (5/7) MSG cases involved Aspergillus and were more likely to have cancer, a transplant, or other immunosuppression compared with clinical cases (Figure 2 and 3). Clinical cases included conditions not specified in MSG criteria, including burns (1), wounds (1) or eye (4) infections. MSG and clinical cases more often had antifungal treatment (16/16 vs. 1/8) or died (4/16 vs. 0/8) compared with non-cases. Conclusion In this preliminary analysis of potential IMI cases, most represented true invasive infections, indicating effective ex

来源：评论

Global Pediatric Pulmonology Alliance recommendations to protect all infants against respiratory syncytial virus with prophylactic monoclonal antibodies

引用

儿科学研究(英文) 2025年第1期

作者： Shen Kunling Rodewald Lance E. Yang Yonghong Wong Gary Wing-Kin Namazova-Baranova Leyla Rosenwasser Lanny J. Alharbi Adel S. Chang Anne B. Goh Anne Muraro Antonella Elnazir Basil Kinane Bernard O’Callaghan Chris Kerem Eitan Hoey Hilary Buttery Jim Wang Jiu-Yao Ouchi Kazunobu Horne Rosemary Triasih Rina Etzel Ruth A. Singh Varinder Li Spencer Guan Yu the Global Pediatric Pulmonology Alliance (GPPA) Council Beijing Children’s Hospital Capital Medical University National Center for Children’s Health Beijing China Shenzhen Children’s Hospital Shenzhen Guangdong China National Immunization Program Chinese Center for Disease Control and Prevention Beijing China Department of Peadiatrics TS Lo Foundation Hong Kong China Department of Paediatrics Chinese University of Hong Kong Hong Kong China Pediatrics and Child Health Research Institute Central Clinical Hospital Russian Academy of Sciences Moscow Russian Federation Anschutz School of Medicine University of Colorado Aurora Colorado USA Prince Sultan Military Medical City (PSMMC) Ministry of Defense Riyadh Saudi Arabia Queensland Children’s Hospital Brisbane Australia and Menzies School of Health Research Darwin Australia KK Women’s and Children’s Hospital Singapore Singapore Food Allergy Referral Centre Veneto Region Padua University Hospital Padua Italy Children’s Health Ireland and Trinity College Dublin Dublin Ireland Division of Pediatric Pulmonary Medicine Massachusetts General Hospital Boston Massachusetts USA UCL Great Ormond Street Institute of Child Health Great Ormond Street Hospital (GOSH) BRC University College London London UK Pediatric Pulmonology Unit Hadassah Medical Center Jerusalem Israel Department of Pediatrics University of Dublin Trinity College Dublin Ireland Department of Paediatrics University of Melbourne Melbourne Australia College of Medicine National Cheng Kung University Taiwan China Department of Pediatrics Kawasaki Medical School Kurashiki-City Japan Department of Peadiatrics Monash University Melbourne Australia Department of Paediatric Faculty of Medicine Public Health and Nursing Universitas Gadjah Mada/Dr. Sardjito Hospital Yogyakarta Indonesia Environmental &amp Occupational Health Milken Institute School of Public Health George Washington University Washington District of Columbia USA Lady Hardinge Medical College Association Kalawati Saran Children’s Hospital

来源：评论

Cover Image, Volume 59, Issue 7

引用

Molecular Carcinogenesis 2020年第7期59卷

作者： Elizabeth Mitchell Sonali Jindal Tiffany Chan Jayasri Narasimhan Shamilene Sivagnanam Elliot Gray Young Hwan Chang Sheila Weinmann Pepper Schedin Department of Cell Developmental and Cancer Biology Oregon Health and Science University Portland Oregon Cancer Prevention and Control Knight Cancer Institute Oregon Health and Science University Portland Oregon Computational Biology Program Department of Cell Developmental and Cancer Biology Oregon Health and Science University Portland Oregon Department of Biomedical Engineering Oregon Center for Spatial Systems Biomedicine Oregon Health and Science University Portland Oregon Center for Health Research Kaiser Permanente Northwest Portland Oregon

来源：评论

Association Between Household Food Security and Disordered Eating Behaviors Among Young Adults with Diabetes: The SEARCH for Diabetes in Youth Study

引用

Current Developments in Nutrition 2020年第SUPPL 2期4卷 4141419-4141419页

作者： Jackson, Emahlea Liese, Angela Pihoker, Catherine Malik, Faisal Jones-Smith, Jessica Qu, Pingping Crow, Scott Loots, Beth Reboussin, Beth Dolan, Lawrence Igudesman, Daria Sauder, Katherine Shapiro, Allison Siegel, Karen Turley, Christine Mendoza, Jason University of Washington University of South Carolina Seattle Children's Research Institution Seattle Children's Research Institute The Emily Program St. Paul MN University of Minnesota Wake Forest University School of Medicine University of Cincinnati University of North Carolina at Chapel Hill University of Colorado Denver University of Colorado Anschutz Medical Campus Centers for Disease Control and Prevention Emory University Medical University of South Carolina Fred Hutchinson Cancer Research Center

AbstractObjectivesExamine the relationship between household food insecurity (HFS; i.e., access to nutritionally adequate and safe food) and disordered eating behaviors (i.e., restriction, bingeing, insulin manipulati...

AbstractObjectivesExamine the relationship between household food insecurity (HFS; i.e., access to nutritionally adequate and safe food) and disordered eating behaviors (i.e., restriction, bingeing, insulin manipulation, etc.) among a sample of young adults with youth-onset type 1 (T1D) or type 2 diabetes (T2D). MethodsWe used cross-sectional data from the SEARCH for Diabetes in Youth Study. Individuals ( n = 792) ages ≥18 years completed the U.S. Household Food Security Survey Module and the Diabetes Eating Problem Survey-Revised (DEPS-R) between 2016 and 2019. We converted HFS scores to a 10-point scale and dichotomized scores into food secure (HFS ≤ 2.2) vs. food insecure (HFS > 2.2). Multivariable linear regression was used to evaluate the association of HFS with continuous DEPS-R score (i.e., 0–80, with a greater score indicating greater symptoms of disordered eating), adjusting for potential confounders (i.e., sex, age, race/ethnicity, education, household income, insurance, depressive symptoms, and duration of diabetes). We further stratified analyses by diabetes type. ResultsParticipants were on average 23.8 ± 3.7 years, 59.6% female, 49.6% non-Latino white, and had a mean diabetes duration of 11.5 ± 3.1 years. The overall mean DEPS-R score was 17.3 ± 10.0 points. Mean DEPS-R scores in individuals living in food secure households ( n = 709) and food insecure households ( n = 83) were 16.6 ± 9.45 and 23.4 ± 12.4, respectively. The adjusted DEPS-R scores were 3.6 points (95% CI = 1.5, 5.7; P < 0.001) higher in food insecure compared to food secure households. In individuals with T1D ( n = 600), the adjusted DEPS-R scores were 5.0 points (95% CI = 2.6, 7.4; P < 0.001) higher in food insecure ( n = 55) compared to food secure ( n = 545) households. In individuals with T2D ( n = 192), there was no significant difference in mean DEPS-R scores between food insecure ( n = 28) versus food secure ( n = 164) households in unadjusted or adjusted models ( P > 0.05). Conc

来源：评论

Correction to: Machine Learning for Identifying Emotional Expression in Text: Improving the Accuracy of Established Methods

引用

Journal of technology in behavioral science 2020年第4期5卷 416页

作者： Erin Bantum Noémie Elhadad Jason E Owen Shaodian Zhang Mitch Golant Joanne Buzaglo Joanne Stephen Janine Giese-Davis Cancer Prevention & Control Program University of Hawaii Cancer Center Honolulu HI USA. Biomedical Informatics Columbia University New York NY USA. Dissemination & Training Division VA Palo Alto Health Care System Livermore CA USA. Cancer Support Community Washington DC USA. Alberta Health Services Calgary Alberta Canada. Cumming School of Medicine Department of Oncology University of Calgary Calgary Alberta Canada.

[This corrects the article PMC7467127.].

来源：评论

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案：

请选择收藏分类：

通借通还

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：